Clinical Laserthermia Systems AB (FRA:LS60) 3-1 Month Momentum %: -29.87% (As of Jul. 27, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:LS60 Clinical Laserthermia Systems AB FRA:LS60
41 GF Score
Price €0.13
GF Value €0.21
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Clinical Laserthermia Systems AB 3-1 Month Momentum %?

Clinical Laserthermia Systems AB FRA:LS60 -44.14% 41 3-1 Month Momentum % is -29.87% as of Jul. 27, 2026. GuruFocus rates FRA:LS60 with a GF Score™ of 41/100 and a GF Value™ of €0.21 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 846 Medical Devices & Instruments companies, Clinical Laserthermia Systems AB ranks worse than 79.67% on this metric.

3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-07-27), Clinical Laserthermia Systems AB's 3-1 Month Momentum % is -29.87%.

The industry rank for Clinical Laserthermia Systems AB's 3-1 Month Momentum % or its related term are showing as below:

FRA:LS60's 3-1 Month Momentum % is ranked worse than
79.67% of 846 companies
in the Medical Devices & Instruments industry
Industry Median: -9.14 vs FRA:LS60: -29.87

Clinical Laserthermia Systems AB  (FRA:LS60) 3-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Clinical Laserthermia Systems AB 3-1 Month Momentum % Related Terms


FRA:LS60 vs ABT, SYK, MDT: 3-1 Month Momentum % Comparison

For the Medical Devices subindustry, Clinical Laserthermia Systems AB's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Clinical Laserthermia Systems AB 3-1 Month Momentum % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Clinical Laserthermia Systems AB's 3-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Clinical Laserthermia Systems AB's 3-1 Month Momentum % falls into.


FRA:LS60
41GF Score
Clinical Laserthermia Systems AB FRA:LS60
3-1 Month Momentum % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Clinical Laserthermia Systems AB  (FRA:LS60) 3-1 Month Momentum % Calculation

3-1 Month Momentum % is calculated as following:

3-1 Month Momentum %=( Price 1-month ago / Price 3-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about 3-1 Month Momentum % →
What does a 3-1 Month Momentum % of -29.87% mean?
Clinical Laserthermia Systems AB (FRA:LS60) has a 3-1 Month Momentum % of -29.87% as of Jul. 27, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Clinical Laserthermia Systems AB and its competitors. According to the industry distribution chart, Clinical Laserthermia Systems AB ranks #674 out of 846 companies in the Medical Devices & Instruments industry, placing it in the top 79.7%.
Is Clinical Laserthermia Systems AB's 3-1 Month Momentum % too high?
Clinical Laserthermia Systems AB's current 3-1 Month Momentum % is -29.87%. Based on the distribution chart, Clinical Laserthermia Systems AB ranks #674 out of 846 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Clinical Laserthermia Systems AB has a GF Score™ of 41/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Clinical Laserthermia Systems AB's 3-1 Month Momentum % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Clinical Laserthermia Systems AB ranks #674 out of 846 companies for 3-1 Month Momentum %. This places Clinical Laserthermia Systems AB in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for a Medical Devices & Instruments company?
A good 3-1 Month Momentum % depends on the Medical Devices & Instruments industry context. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Clinical Laserthermia Systems AB and its competitors. Clinical Laserthermia Systems AB's current 3-1 Month Momentum % is -29.87%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Clinical Laserthermia Systems AB stock overvalued right now?
Based on GuruFocus' analysis, Clinical Laserthermia Systems AB (FRA:LS60) is currently considered Possible Value Trap. The stock's GF Value™ is €0.21, compared to a current price of €0.13 — trading 39% below its estimated fair value. The current 3-1 Month Momentum % is -29.87%. Clinical Laserthermia Systems AB's overall GF Score™ is 41/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For Clinical Laserthermia Systems AB (FRA:LS60), the current 3-1 Month Momentum % is -29.87% as of Jul. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Clinical Laserthermia Systems AB (FRA:LS60) Overvalued in 2026?

Based on GuruFocus' analysis, Clinical Laserthermia Systems AB stock appears to be undervalued. The current stock price of €0.13 is trading 39% below its estimated GF Value™ of €0.21. GuruFocus considers Clinical Laserthermia Systems AB to be Possible Value Trap.

Key valuation signals for FRA:LS60:

  • 3-1 Month Momentum %: -29.87%
  • GF Value™: €0.21 vs. price of €0.13 (39% below fair value)
  • GF Score™: 41/100 with 5 warning signs

No single metric tells the full story. See the FRA:LS60 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Clinical Laserthermia Systems AB Business Description

Other Exchanges CLS B:Sweden
Address Scheelevagen 2, Medicon village, Lund, SWE, 223 81
Clinical Laserthermia Systems AB develops and sells single-use products used during each treatment procedure of treatment of solid tumors cancers. Its products include Thermal Therapy System, Mobile Laser Unit, Laser Applicator Non-cooled and Tissue Temp Probe.
41GF Score

Get the complete analysis for FRA:LS60

3-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.13
Price
€0.21
GF Value